)
)
InMed Pharmaceuticals Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from InMed Pharmaceuticals Inc
Access all reports
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. It uses its drug development programs to treat diseases with high unmet medical need. The company's product pipelines include Epidermolysis Bullosa, Glucocerebrosidase Deficiency, Ocular Scarring, and Transdermal Cannabinoid delivery system. Its platform technology includes Biosynthesis process for natural plant-based cannabinoids, Bioinformatics databases to assess the pharmacological activity of existing and novel cannabinoids, and Drug delivery platforms that provide targeted therapeutic options. The company was formerly known as InMed BioPharma Inc. and changed its name to InMed Pharmaceuticals Inc. in December 2016. InMed Pharmaceuticals Inc. was founded in 2011 and is based in Vancouver, Canada.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
INM
Country
🇺🇸 United States